← Catalyst calendarCELU biotech catalysts & pipeline
CELULARITY INC · Data as of 2026-09-08
Upcoming catalysts
FUSE Bone Void Filler (FUSE) — NDA/BLA submission
H2 2026
We expect to advance the development of our FUSE Bone Void Filler, or FUSE, with the objective of a 510(k) filing in the second half of 2026, and to advance the development of our Celularity Placental Matrix, or CPM, with the objective of a 510(k) filing in the second half of 2027.
Source filingCelularity Placental Matrix (CPM) — NDA/BLA submission
H2 2027
We expect to advance the development of our FUSE Bone Void Filler, or FUSE, with the objective of a 510(k) filing in the second half of 2026, and to advance the development of our Celularity Placental Matrix, or CPM, with the objective of a 510(k) filing in the second half of 2027.
Source filingExplore the free biotech catalyst calendar